SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Levofloxacin prophylaxis in patients with myeloma - Authors' reply.

Drayson, MT; Bowcock, S; Planche, T; Iqbal, G; Pratt, G; Yong, K; Dunn, JA (2020) Levofloxacin prophylaxis in patients with myeloma - Authors' reply. Lancet Oncol, 21 (2). e69. ISSN 1474-5488 https://doi.org/10.1016/S1470-2045(20)30020-6
SGUL Authors: Planche, Timothy David

[img] Microsoft Word (.docx) Accepted Version
Restricted to Repository staff only until 30 July 2020.
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (22kB)

Item Type: Article
Additional Information: © 2020. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/
Keywords: 1112 Oncology and Carcinogenesis, Oncology & Carcinogenesis
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: Lancet Oncol
ISSN: 1474-5488
Language: eng
Dates:
DateEvent
February 2020Published
30 January 2020Published Online
10 January 2020Accepted
Publisher License: Creative Commons: Attribution-Noncommercial-No Derivative Works 4.0
PubMed ID: 32007200
Go to PubMed abstract
URI: http://openaccess.sgul.ac.uk/id/eprint/111629
Publisher's version: https://doi.org/10.1016/S1470-2045(20)30020-6

Actions (login required)

Edit Item Edit Item